- Home
- SPT vs IMCR Comparison
SPT vs IMCR Comparison
Compare SPT & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPT
- IMCR
- Stock Information
- Founded
- SPT 2010
- IMCR 2008
- Country
- SPT United States
- IMCR United Kingdom
- Employees
- SPT N/A
- IMCR N/A
- Industry
- SPT Computer Software: Prepackaged Software
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPT Technology
- IMCR Health Care
- Exchange
- SPT Nasdaq
- IMCR Nasdaq
- Market Cap
- SPT 1.9B
- IMCR 1.5B
- IPO Year
- SPT 2019
- IMCR 2021
- Fundamental
- Price
- SPT $33.03
- IMCR $30.00
- Analyst Decision
- SPT Buy
- IMCR Buy
- Analyst Count
- SPT 15
- IMCR 13
- Target Price
- SPT $45.92
- IMCR $65.18
- AVG Volume (30 Days)
- SPT 497.9K
- IMCR 298.2K
- Earning Date
- SPT 02-25-2025
- IMCR 02-26-2025
- Dividend Yield
- SPT N/A
- IMCR N/A
- EPS Growth
- SPT N/A
- IMCR N/A
- EPS
- SPT N/A
- IMCR N/A
- Revenue
- SPT $392,402,000.00
- IMCR $296,312,000.00
- Revenue This Year
- SPT $22.78
- IMCR $28.91
- Revenue Next Year
- SPT $14.58
- IMCR $12.65
- P/E Ratio
- SPT N/A
- IMCR N/A
- Revenue Growth
- SPT 26.70
- IMCR 25.09
- 52 Week Low
- SPT $25.05
- IMCR $27.69
- 52 Week High
- SPT $68.41
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- SPT 57.88
- IMCR 50.53
- Support Level
- SPT $29.48
- IMCR $28.22
- Resistance Level
- SPT $33.38
- IMCR $30.77
- Average True Range (ATR)
- SPT 1.23
- IMCR 1.35
- MACD
- SPT 0.10
- IMCR 0.08
- Stochastic Oscillator
- SPT 88.53
- IMCR 51.90
About SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. The firm generates majority revenue from software subscriptions.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.